0       0

2017 Annual Meeting


036 - SESSION 36: CAV: New Insights to an Old Problem


Apr 7, 2017 4:00pm ‐ Apr 7, 2017 5:30pm

Description

(359) Sirolimus-Based Immunosuppression Mitigates Progression of Cardiac Allograft Vasculopathy and Improves Cardiac Outcomes After Heart Transplantation: A Single Center 15-Year Follow-Up Study
Rabea Asleh, MD, PhD

(360) Early Aspirin Initiation Following Heart Transplantation Decreases the Risk of Allograft Vasculopathy During Long-Term Follow-Up
Yael Peled, MD

(361) Atheroprotective Effect of IgM Anti-Phosphorylcholine Natural Antibodies in Heart Transplant Patients
Carlos Labarrere, MD

(362) IgM Anti-Phosphorylcholine, Inflammation and Thrombosis: Effects on Heart Transplant Outcomes
Carlos Labarrere, MD

(363) Early Changes in the Coronary Microstructure After Heart Transplantation: A Prospective Optical Coherence Tomography Study
Tor Clemmensen, MD

(364) Markers of Intermediate-Term Risk After Heart Transplant - Results of the CTOT-18 Study
Josef Stehlik, MD, MPH

Speaker(s):

  • Rabea Asleh, MD, PhD, Mayo Clinic, Rochester, MN, United States
  • Yael Peled, MD, Sheba Medical Center, Tel Hashomer, Israel
  • Carlos Labarrere, MD, California Medical Innovations Institute
  • Tor Clemmensen, MD, Aarhus University Hospital, Skejby, Denmark
  • Josef Stehlik, MD, MPH, University of Utah School of Medicine, Salt Lake City, UT, United States
Tags: PHARM BSTR PATH HTX

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content